Secondary Prevention After Myocardial Infarction: What to Do and Where to Do It

Overview

Journal Rev Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Jul 30

PMID 39077194

Authors

Vladimir Tuka

Josef Holub

Jan Belohlavek

Affiliations

Soon will be listed here.

Abstract

Acute myocardial infarction is a manifestation of atherosclerosis which may be fatal. In-hospital and short-term mortality rates after an acute myocardial infarction have declined in the past few decades. However, although long-term mortality has decreased, it remains unacceptably high. This review paper summarises the non-pharmacological interventions (smoking cessation, physical activity, nutrition, and psychosocial intervention) and pharmacological approaches (antiplatelet and lipid-lowering therapy, renin-angiotensin-aldosterone system inhibitors, beta-blockers, and glucose-lowering drugs) to secondary prevention after a myocardial infarction. The provision of secondary prevention services is established through cardiac rehabilitation, which consists of several discussed components. Finally, we discuss the quality indicators for long-term care after an acute myocardial infarction.

Citing Articles

Splicing factor SRSF1 attenuates cardiomyocytes apoptosis via regulating alternative splicing of Bcl2L12.

Xie Y, Yang Z, Chen W, Zhong C, Li M, Zhang L Cell Biosci. 2024; 14(1):142.

PMID: 39578852 PMC: 11585136. DOI: 10.1186/s13578-024-01324-3.

References

Claessen B, Guedeney P, Gibson C, Angiolillo D, Cao D, Lepor N . Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review. J Am Heart Assoc. 2020; 9(24):e018897. PMC: 7955383. DOI: 10.1161/JAHA.120.018897. View

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Ray K, Wright R, Kallend D, Koenig W, Leiter L, Raal F . Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol. N Engl J Med. 2020; 382(16):1507-1519. DOI: 10.1056/NEJMoa1912387. View

Nabel E, Braunwald E . A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012; 366(1):54-63. DOI: 10.1056/NEJMra1112570. View

Lindenauer P, Remus D, Roman S, Rothberg M, Benjamin E, Ma A . Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007; 356(5):486-96. DOI: 10.1056/NEJMsa064964. View

Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L . Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004; 25(22):1990-7. DOI: 10.1016/j.ehj.2004.09.021. View

Tardif J, Karwatowska-Prokopczuk E, Amour E, Ballantyne C, Shapiro M, Moriarty P . Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk. Eur Heart J. 2022; 43(14):1401-1412. PMC: 8986458. DOI: 10.1093/eurheartj/ehab820. View

Habib G, Yousuf H, Narula J, Hofstra L . Call to action: cardiologists should promote influenza vaccination. Neth Heart J. 2021; 29(11):545-550. PMC: 8515147. DOI: 10.1007/s12471-021-01637-9. View

Rea T, Heckbert S, Kaplan R, Smith N, Lemaitre R, Psaty B . Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med. 2002; 137(6):494-500. DOI: 10.7326/0003-4819-137-6-200209170-00009. View

10.

Griffo R, Ambrosetti M, Tramarin R, Fattirolli F, Temporelli P, Vestri A . Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey. Int J Cardiol. 2012; 167(4):1390-5. DOI: 10.1016/j.ijcard.2012.04.069. View

11.

Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D . European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022; 43(8):716-799. DOI: 10.1093/eurheartj/ehab892. View

12.

Gencer B, Mach F, Murphy S, De Ferrari G, Huber K, Lewis B . Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial. JAMA Cardiol. 2020; 5(8):952-957. PMC: 7240652. DOI: 10.1001/jamacardio.2020.0882. View

13.

Gibbs B, Hivert M, Jerome G, Kraus W, Rosenkranz S, Schorr E . Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association. Hypertension. 2021; 78(2):e26-e37. DOI: 10.1161/HYP.0000000000000196. View

14.

Ibanez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci C, Bueno H . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European.... Eur Heart J. 2017; 39(2):119-177. DOI: 10.1093/eurheartj/ehx393. View

15.

Chow C, Jolly S, Rao-Melacini P, Fox K, Anand S, Yusuf S . Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010; 121(6):750-8. DOI: 10.1161/CIRCULATIONAHA.109.891523. View

16.

Thomas R, Beatty A, Beckie T, Brewer L, Brown T, Forman D . Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol. 2019; 74(1):133-153. PMC: 7341112. DOI: 10.1016/j.jacc.2019.03.008. View

17.

Borg S, Oberg B, Leosdottir M, Lindolm D, Nilsson L, Back M . Factors associated with non-attendance at exercise-based cardiac rehabilitation. BMC Sports Sci Med Rehabil. 2019; 11:13. PMC: 6660668. DOI: 10.1186/s13102-019-0125-9. View

18.

Anderson L, Oldridge N, Thompson D, Zwisler A, Rees K, Martin N . Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2016; 67(1):1-12. DOI: 10.1016/j.jacc.2015.10.044. View

19.

Moheimani R, Bhetraratana M, Peters K, Yang B, Yin F, Gornbein J . Sympathomimetic Effects of Acute E-Cigarette Use: Role of Nicotine and Non-Nicotine Constituents. J Am Heart Assoc. 2017; 6(9). PMC: 5634299. DOI: 10.1161/JAHA.117.006579. View

20.

Amor-Salamanca A, Castillo S, Gonzalez-Vioque E, Dominguez F, Quintana L, Lluis-Ganella C . Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome. J Am Coll Cardiol. 2017; 70(14):1732-1740. DOI: 10.1016/j.jacc.2017.08.009. View